203167 Phase 2a in Psoriasis
ELU-4-EA431B-1

Psoriasis Phase 2a clinical study.


Primary Purpose
203167 Phase 2a in Psoriasis
Study Types
C71104
Description of Cohorts
Psoriasis Phase 2a clinical study. PLSS, PASI, and PGA longitudinal data of all placebo subjects. Histology data of lesional biopsies from placebo subjects at days 1 and 43. Transcriptomic data of lesional biopsies and whole blood from placebo subjects at days 1 and 43.
Informed Consent Given?
True
Multi-center Study?
-
Organisms
Homo sapiens
Number of subjects
-
Diseases
Psoriasis
Sample Sources
Tissue Sample
Type of Samples Collected
Blood Tissue